Fmoc-L-beta-homotryptophan,
353245-98-4,
(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(1H-indol-3-yl)butanoic acid,
(3S)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-(1H-indol-3-yl)butanoic acid,
(3S)-3-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-4-(1H-indol-3-yl)butanoic acid,
AK162619,
Fmoc-beta-Homotrp-OH,
Fmoc-L-|A-Homo-Trp-OH,
AC1MC57M,
SCHEMBL119237,
CTK7G2313,
KS-00000GB0,
ZINC2386927,
MFCD01863056,
AKOS015948889,
DS-7883,
FL765-1,
RTR-062334,
AC-22098,
ACM353245984,
AX8131275,
TR-062334,
CS-0062195,
Fmoc-beta-Homotrp-OH, >=96.0% (HPLC),
FT-0774463,
(3S)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-(1H-indol-3-yl)butyric acid,
(3S)-3-[[9H-fluoren-9-ylmethoxy(oxo)methyl]amino]-4-(1H-indol-3-yl)butanoic acid,
(S)-3-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-4-(1H-INDOL-3-YL)-BUTYRIC ACID,
ACN-026031,
CID2761552,
1H-Indole-3-butanoic acid, beta-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (betaS)-,
3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-(1H-indol-3-yl)butanoic Acid,